Vishal Kapoor

IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ.

Amplitude Healthcare Acquisition Corp. operates as a blank check company. It aims to acquire one or more businesses and assets through a merger, share purchase and reorganization. The company was founded on August 13, 2019 and is headquartered in New York, NY.

NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ.

Avego Healthcare Capital LLC operates as a private equity firm specializing in growth capital and late stage transactions. It invests in cycle management, under-resourced products, healthcare services, biopharmaceutical services, contract research organizations, clinical study sites, contract development organizations, contract manufacturing organizations, API manufacturing, contract packaging, niche/specialty services, unskilled home health, highly specialized procedure centers. The company was founded by Balaji K. Venkataraman in 2015 and is headquartered in Alpharetta, GA.

Avego Management LLC is a healthcare-focused investment firm that was founded in 2015 by former healthcare entrepreneurs. The private company is based in Alpharetta, GA. The company has offices in multiple locations and operates through three strategies: private equity, venture capital, and a long/short fund. Avego invests in private and public companies that develop and commercialize innovative healthcare products and services for patients, practitioners, and other stakeholders. The company's mission is to use its industry expertise and capital to deliver successful results and improve the lives of patients.